Thailand - Delayed Quote THB

Vibhavadi Medical Center Public Company Limited (VIBHA.BK)

2.2800 0.0000 (0.00%)
At close: April 26 at 4:36 PM GMT+7
Currency in THB All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
8,173,497.3160
8,173,497.3160
8,612,233.2550
7,373,426.2470
6,024,448.9070
Cost of Revenue
5,834,024.1950
5,834,024.1950
5,875,991.8510
5,179,224.0410
4,485,881.3420
Gross Profit
2,339,473.1210
2,339,473.1210
2,736,241.4040
2,194,202.2060
1,538,567.5650
Operating Expense
1,041,934.5140
1,041,934.5140
970,064.5900
827,184.1870
803,324.3510
Operating Income
1,297,538.6070
1,297,538.6070
1,766,176.8140
1,367,018.0190
735,243.2140
Net Non Operating Interest Income Expense
-306,335.7780
-306,335.7780
-244,811.1200
-206,041.3470
-202,720.7250
Other Income Expense
280,141.3000
280,141.3000
431,784.2570
1,052,894.2220
149,326.7520
Pretax Income
1,271,344.1290
1,271,344.1290
1,953,149.9510
2,213,870.8940
681,849.2410
Tax Provision
196,838.9380
196,838.9380
302,021.9070
224,391.2280
127,657.2770
Net Income Common Stockholders
865,124.8360
865,124.8360
1,339,745.5330
1,805,050.1970
465,472.8200
Diluted NI Available to Com Stockholders
865,124.8360
865,124.8360
1,339,745.5330
1,805,050.1970
465,472.8200
Basic EPS
0.06
--
0.10
0.13
0.03
Diluted EPS
0.06
--
0.10
0.12
0.03
Basic Average Shares
13,576,011.4740
--
13,575,945.9230
13,575,865.5820
13,414,288.5940
Diluted Average Shares
13,576,011.4740
--
13,575,945.9230
14,887,489.5140
14,783,112.1980
Total Operating Income as Reported
1,503,935.8200
1,503,935.8200
2,062,252.9190
1,698,223.7270
946,924.6550
Rent Expense Supplemental
41,092.8040
41,092.8040
37,328.4580
36,406.2600
79,845.4960
Total Expenses
6,875,958.7090
6,875,958.7090
6,846,056.4410
6,006,408.2280
5,289,205.6930
Net Income from Continuing & Discontinued Operation
865,124.8360
865,124.8360
1,339,745.5330
1,805,050.1970
465,472.8200
Normalized Income
690,677.9116
690,677.9116
1,112,728.4759
1,545,726.9836
293,418.1448
Interest Expense
306,335.7780
306,335.7780
244,811.1200
206,041.3470
202,720.7250
Net Interest Income
-306,335.7780
-306,335.7780
-244,811.1200
-206,041.3470
-202,720.7250
EBIT
1,577,679.9070
1,577,679.9070
2,197,961.0710
2,419,912.2410
884,569.9660
EBITDA
2,224,190.0410
2,224,190.0410
2,822,464.5630
2,920,912.6940
1,323,257.6900
Reconciled Cost of Revenue
5,834,024.1950
5,834,024.1950
5,875,991.8510
5,179,224.0410
4,485,881.3420
Reconciled Depreciation
646,510.1340
646,510.1340
624,503.4920
501,000.4530
438,687.7240
Net Income from Continuing Operation Net Minority Interest
865,124.8360
865,124.8360
1,375,635.1560
1,843,414.6740
465,472.8200
Total Unusual Items Excluding Goodwill
206,397.2130
206,397.2130
310,984.9540
331,205.7080
211,681.4410
Total Unusual Items
206,397.2130
206,397.2130
310,984.9540
331,205.7080
211,681.4410
Normalized EBITDA
2,017,792.8280
2,017,792.8280
2,511,479.6090
2,589,706.9860
1,111,576.2490
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0001
0.0002
Tax Effect of Unusual Items
31,950.2886
31,950.2886
48,078.2739
33,518.0176
39,626.7658
12/31/2020 - 1/20/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers